Peptide PilotPeptide Pilot

Vial duration

TB-500 vial duration calculator

Estimate how many weeks one 5 mg TB-500 vial covers at your dose and weekly cadence.

Download Peptide PilotiPhone · Free to download

Total doses

2

Lasts

1.0 weeks

TB-500 is a synthetic fragment of the natural protein Thymosin Beta-4 that people use to support recovery from soft-tissue and tendon injuries. It works by promoting cell migration and new blood-vessel formation at injury sites, which is what allows damaged tissue to rebuild faster. Animal studies show meaningful acceleration of wound and tendon healing; controlled human data is limited. This page covers reconstitution math and how people typically log a loading-then-maintenance schedule.

How the TB-500 vial duration calculator works

This calculator answers the inventory question: at your current dose and weekly cadence, how many weeks will this TB-500 vial last? It is the math you need to plan refills before a vial runs dry mid-protocol — especially with peptides like GLP-1s where shipping windows can run several weeks.

The formula is two divisions. Total doses per vial equals vial mg divided by dose mg, rounded down. Weeks of supply equals total doses divided by doses per week. With a 5 mg vial of TB-500, a 2 mg dose, and 2 dose per week, the vial covers 2 doses, or about 1.0 weeks of supply.

The three inputs that move the answer: vial mg (set when you bought the vial), dose mg (set by your protocol step), and doses-per-week (set by the peptide's half-life). Once a vial is reconstituted it also has a stability ceiling — most lyophilized peptides reconstituted in BAC water are typically used within four to six weeks of refrigerated storage, so a vial that mathematically lasts twelve weeks may not last twelve weeks in practice.

Use this calculator before opening a new vial to confirm the dose and cadence you have planned will not strand you halfway through. Use it again whenever you titrate up — a dose increase shortens vial life, sometimes dramatically. The calculator is intentionally conservative: it floors total doses, never assumes partial-dose draws, and never extends weeks beyond what whole doses support.

TB-500 cadence and how it changes vial life

Logs documenting TB-500 administration most often show a subcutaneous cadence of once or twice per week, a pattern consistent with a molecule expected to have a prolonged duration of action. Some experimental designs incorporate an initial loading phase, where administration might occur several times per week for one to four weeks, before transitioning to a less frequent maintenance schedule. Due to the milligram-scale doses, a 1mL or 0.5mL U-100 insulin syringe is typically used to accurately draw the calculated volume from the reconstituted vial. Rotation of injection sites is a standard practice recorded in detailed logs to monitor for any localized skin reactions.

When planned in conjunction with a peptide requiring daily administration, like BPC-157, TB-500 is scheduled on its own rhythm within the week. A tracker might record daily BPC-157 entries while logging TB-500 doses only on Mondays and Thursdays, for example. This separation ensures that each protocol can be monitored independently without complex timing interactions. The precise time of day for a TB-500 dose is often considered less critical than for short-acting peptides, as the goal is to maintain a stable systemic concentration over many days rather than targeting a narrow post-injection activity window.

Storage and shelf life for TB-500

For optimal stability, the unmixed, lyophilized form of TB-500 is stored under refrigeration away from light. After the peptide powder is reconstituted with a sterile diluent, the vial containing the solution should also be kept in a cold, dark environment like a refrigerator. Researchers typically plan to use the contents of the reconstituted vial within a defined timeframe, often several weeks, to minimize potential degradation of the peptide in solution.

Tracking TB-500 vials in a real log

When implementing a twice-weekly protocol, the most important detail to log is the strict adherence to the chosen administration days to maintain a consistent interval. A common deviation is schedule drift, where a missed Thursday dose is taken on Friday, and the subsequent dose shifts from Monday to Tuesday, gradually extending the time between doses. To prevent this, a log should explicitly state the intended schedule (e.g., 'Monday/Thursday') and record the actual date and time of each dose. This rigorous documentation ensures that any observed outcomes can be correlated with a consistent and verifiable administration timeline.

Common TB-500 vial-planning mistakes

  • Assuming the same unit measurement as BPC-157 when they are stacked, leading to a significant under-dose of TB-500 due to its milligram-scale dosing.
  • Entering a 2.5 mg dose into a calculator field that defaults to micrograms (mcg), resulting in a miscalculation of several orders of magnitude.
  • Allowing a twice-weekly schedule to drift by a day each week, altering the dosing interval from a 3-day/4-day pattern to a 4-day/5-day pattern over time.
  • Using only 1 mL of diluent for a 10 mg vial and finding the resulting solution too concentrated to measure small dose adjustments precisely on a U-100 syringe.
  • Failing to log the 'loading' phase parameters separately from the 'maintenance' phase, making it difficult to analyze the distinct periods of the protocol later.

Frequently asked questions about TB-500 vial duration

Why are TB-500 doses measured in milligrams (mg) while many others are in micrograms (mcg)?
The dosage scale is related to the peptide's molecular structure and the concentrations studied in research literature. TB-500 is a fragment of a larger, naturally abundant protein, and the quantities examined for biological activity are correspondingly higher than those for smaller synthetic peptides that act on highly sensitive receptors. This difference in magnitude necessitates using milligrams as the unit of measurement for accurate planning, calculation, and tracking.
If I use a 5 mg vial and 2 mL of diluent, how many units do I draw for a 2 mg dose?
With a 5 mg vial reconstituted with 2 mL of bacteriostatic water, the concentration becomes 2.5 mg per mL. To calculate a 2 mg dose, you would need 0.8 mL of the solution. On a U-100 insulin syringe, where 100 units equal 1 mL, 0.8 mL is equal to 80 units. Using a dose calculator is the most reliable way to convert your desired milligram dose into the correct syringe units.
What is the rationale behind a twice-weekly administration schedule?
The less frequent administration schedule, such as twice per week, documented in research logs for TB-500 is generally associated with a longer biological half-life compared to peptides requiring daily or more frequent dosing. This allows for sustained systemic levels to be maintained without the logistic complexity of daily administration. The specific interval (e.g., Monday/Thursday) is chosen to keep peptide concentrations relatively consistent throughout the week.
How does TB-500's mechanism differ from that proposed for BPC-157?
Research suggests they operate through different primary pathways. TB-500's proposed mechanism involves modulating actin dynamics, a fundamental intracellular process for cell structure and migration. In contrast, BPC-157 is primarily studied for its influence on the nitric oxide (NO) system and its effects on angiogenesis (the formation of new blood vessels), largely extracellular and signaling-based activities. Because these mechanisms are distinct, they are often studied in combination to observe their potentially complementary roles.
Is a 'loading phase' documented in research protocols?
Some logs and research reports document a 'loading phase,' characterized by more frequent or higher doses for an initial period, followed by a lower-dose 'maintenance phase.' The theory is to more rapidly elevate systemic concentrations to a steady state. However, other protocols begin directly with a maintenance-style cadence. Tracking logs show both approaches being used, and the decision to use a loading phase is a key variable to document when planning and reviewing a research cycle.
Can I pre-load syringes with TB-500 for a week?
Pre-loading syringes introduces additional stability variables, primarily concerning the interaction of the reconstituted peptide with the syringe materials over time. The stability of most peptides is best characterized in sterile glass vials, not in plastic syringes where factors like surface adsorption and interaction with the rubber plunger are unknown. For this reason, the standard practice documented is to draw each dose from the refrigerated vial immediately before administration to ensure consistency and minimize potential degradation.

Related on Peptide Pilot

Track TB-500 vials automatically

Download on the App Store
Get the App